Hansoh Pharmaceutical Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Hansoh Pharmaceutical Group şirketinin toplam hissedar öz sermayesi CN¥27.9B ve toplam borcu CN¥40.3M olup, bu da borç-öz sermaye oranını 0.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥31.7B ve CN¥3.8B dir. Hansoh Pharmaceutical Group 'in FAVÖK'ü CN¥4.2B faiz karşılama oranı -4.1 dur. Şirketin CN¥23.5B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
0.1%
Borç/özkaynak oranı
CN¥40.26m
Borç
| Faiz karşılama oranı | -4.1x |
| Nakit | CN¥23.50b |
| Eşitlik | CN¥27.90b |
| Toplam yükümlülükler | CN¥3.77b |
| Toplam varlıklar | CN¥31.67b |
Son finansal sağlık güncellemeleri
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Recent updates
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 3692 'nin kısa vadeli varlıkları ( CN¥27.4B ) kısa vadeli yükümlülüklerini ( CN¥3.4B ) aşıyor.
Uzun Vadeli Yükümlülükler: 3692 şirketinin kısa vadeli varlıkları ( CN¥27.4B ) uzun vadeli yükümlülüklerini ( CN¥336.6M ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 3692 şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: 3692 şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 0.1% seviyesine yükseldi.
Borç Kapsamı: 3692 'nin borcu işletme nakit akışı ( 11558% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: 3692 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.